Primary Extrapulmonary Coccidioidomycosis

Primary extrapulmonary coccidioidomycosis is an infection caused by a fungus called Coccidioides that shows itself first outside the lungs, such as in the skin, bones, joints, lymph nodes, or brain coverings (meninges). The original lung infection may be very small or silent, so the doctor may only see the disease in other body parts. This disease starts after a person breathes in tiny fungal spores from dusty soil in certain dry areas of the Americas. The spores travel to the lungs, then in a small number of people the fungus spreads through the blood or lymph system to other organs and causes “extrapulmonary” disease.

Primary extrapulmonary coccidioidomycosis is a fungal infection caused by Coccidioides species (“Valley fever” fungus) in which the main, obvious disease is outside the lungs, such as in skin, bones, joints, lymph nodes, or the brain and spinal cord. The person still usually breathes in the spores first, but instead of staying in the lungs, the fungus spreads through the blood or lymph system to other organs. This form is called “disseminated” or “extrapulmonary” disease and is more serious than a simple lung infection. It is seen more often in people with weak immune systems, pregnancy, diabetes, or certain ethnic backgrounds. Long-term antifungal treatment is almost always needed, often for many months or years, especially for bone, joint, or brain involvement.[1][2][3]

Extrapulmonary disease is rare. Only about 0.5–2% of infections spread beyond the lungs, but when this happens it can be serious. The most common places are the skin, bones, joints, lymph nodes, and the brain and spinal cord (central nervous system).

Primary extrapulmonary coccidioidomycosis is often grouped under the wider name “coccidioidomycosis,” which covers both lung (pulmonary) and outside-lung (extrapulmonary) forms. It is classified as a primary systemic fungal infection and appears in rare-disease and infectious-disease databases.

Other names

Coccidioidomycosis has many other names in medical books and rare-disease lists. These names all refer to the same infection or closely related forms of it.

Some other names include:

• Valley fever

• San Joaquin Valley fever

• Desert fever

• Desert rheumatism

• Posadas-Wernicke disease

• Coccidioides infection

• Primary pulmonary coccidioidomycosis

• Primary extrapulmonary coccidioidomycosis

These names come from the areas where the disease is common (like the San Joaquin Valley) or from doctors who first described the illness.

Types

Doctors often talk about “types” based on which organ outside the lung is mainly involved. The infection is the same fungus, but it looks different in each body part.

• Cutaneous (skin) coccidioidomycosis – mainly nodules, plaques, ulcers, or warty-looking skin lesions.

• Soft-tissue coccidioidomycosis – swelling or abscesses in subcutaneous tissue or muscles.

• Osteoarticular coccidioidomycosis – infection in bones and joints, causing chronic bone pain and arthritis-like swelling.

• Lymph-node coccidioidomycosis – enlarged, sometimes tender lymph nodes, often near the primary site.

• Coccidioidal meningitis – infection of the meninges (coverings of brain and spinal cord), a very serious form.

• Other organ involvement – less often, the fungus can involve eyes, heart valves, liver, or other organs.

These patterns are common when the disease spreads beyond the lungs and may be seen at the first time a patient comes to the clinic.

Causes and risk factors

In simple terms, the direct cause is infection by Coccidioides fungus. The items below are situations or risk factors that make primary extrapulmonary disease more likely or more severe.

1. Breathing in fungal spores in endemic areas – The main cause is inhaling Coccidioides spores from dusty soil in dry regions like parts of the southwestern United States, Mexico, and Central or South America.

2. High amount of exposure (dust storms, digging) – Heavy exposure, such as during construction, farming, or dust storms, increases the chance that the fungus spreads from lungs to other organs.

3. Weakened immune system from HIV infection – People with advanced HIV or low CD4 counts have poor cell-mediated immunity, so the fungus can leave the lungs and cause widespread organ disease.

4. Organ transplantation and anti-rejection medicines – Transplant patients often receive powerful drugs that suppress immunity, which allows Coccidioides to spread and cause extrapulmonary disease.

5. Long-term high-dose corticosteroid use – Medicines like prednisone weaken the body’s T-cell response and make dissemination beyond the lungs much more likely.

6. TNF-alpha inhibitor therapy (for autoimmune disease) – Drugs such as adalimumab and infliximab block important immune pathways and have been linked to severe musculoskeletal and extrapulmonary coccidioidomycosis.

7. Pregnancy, especially third trimester – Hormonal and immune changes in late pregnancy increase the risk of dissemination and severe forms like meningitis or bone disease.

8. Very young age (infants) – Infants have immature immune systems and may develop serious extrapulmonary disease even with a first infection.

9. Older age – Older adults often have weaker immunity or other medical problems, which may allow the fungus to spread beyond the lungs.

10. Certain ethnic backgrounds – People of African, Filipino, Native American, and some other non-white backgrounds have higher risk of disseminated disease for reasons that may be partly genetic.

11. Diabetes mellitus – High blood sugar weakens immune function and is linked to more severe coccidioidomycosis, including extrapulmonary forms.

12. Chronic kidney disease or dialysis – Long-term kidney problems and dialysis treatments are associated with impaired immunity and higher risk of severe fungal infections.

13. Cancer and chemotherapy – Many cancer treatments reduce white blood cell counts and damage immune cells, making it easier for the fungus to spread.

14. Advanced liver disease or alcohol-related liver damage – Liver disease can weaken immune responses and increase complications from systemic infections, including fungal ones.

15. Smoking and chronic lung disease – Long-term lung damage from smoking or COPD may help the fungus establish in the lungs and then spread.

16. High fungal load in the original infection – A large number of inhaled spores can cause more severe initial disease and may make dissemination to skin, bones, or CNS more likely.

17. Delay in diagnosis or no treatment – When the illness is misdiagnosed as simple pneumonia or flu and not treated in high-risk patients, the fungus has more time to spread outside the lungs.

18. Previous or ongoing coccidioidomycosis with incomplete control – Persistent or relapsing infection can later show up as extrapulmonary disease in bones, joints, or meninges.

19. Genetic defects in cell-mediated immunity – Rare inherited problems in immune signaling (such as certain cytokine or receptor defects) can allow severe systemic fungal disease, including this infection.

20. Co-infection with other serious illnesses – Conditions such as other chronic infections or severe malnutrition can weaken the host and favor dissemination of Coccidioides to extrapulmonary sites.

Symptoms and signs

Symptoms depend on which organ is involved. Many patients also have general “whole-body” symptoms.

1. Long-lasting fever – Many patients have fever that keeps coming back or stays high for weeks, showing that the body is fighting a deep infection.

2. Night sweats and chills – People may wake up with soaked clothes or sheets, a common sign of systemic fungal or disseminated infection.

3. Weight loss and tiredness – Ongoing infection often causes loss of appetite, unplanned weight loss, and strong fatigue because the body uses a lot of energy fighting the fungus.

4. Skin nodules or plaques – Firm bumps, raised plaques, or warty lesions can appear on the face, trunk, or limbs when the fungus reaches the skin. They may ulcerate or drain.

5. Skin ulcers or abscesses – Some patients develop open sores or collections of pus in the skin or soft tissues, especially over bones or joints with underlying infection.

6. Painful or enlarged lymph nodes – Lymph nodes in the neck, armpit, groin, or near lesions can swell and become tender as they trap fungal organisms and immune cells.

7. Chronic bone pain – Deep, aching pain in long bones, spine, or ribs suggests bone involvement and may worsen with movement or at night.

8. Swollen, painful joints – Joints such as knees, ankles, or spine may swell and hurt, mimicking arthritis or other joint diseases when the fungus infects bone or joint spaces.

9. Back pain or spinal tenderness – Infection of the vertebrae (spinal bones) can cause severe back pain, difficulty walking, or localized tenderness on pressing the spine.

10. Severe headache – Persistent, strong headaches may signal coccidioidal meningitis, especially in a person from an endemic area with other systemic signs.

11. Neck stiffness and light sensitivity – Stiff neck, nausea, and sensitivity to light are classic signs of meningitis and need urgent evaluation.

12. Confusion or behavior changes – In severe CNS disease, patients may become confused, sleepy, or show personality changes because of increased pressure or inflammation in the brain.

13. Cough or chest discomfort (mild or past) – Even in “primary extrapulmonary” cases, a person may recall a past cough or mild chest pain from the original lung infection.

14. Eye problems (rare) – Blurry vision, eye pain, or redness may appear if the fungus involves ocular tissues, though this is much less common.

15. General feeling of being very unwell – Many people say they “just feel very sick,” with low energy and poor daily functioning, reflecting chronic systemic inflammation.

Diagnostic tests

Doctors use a mix of clinical exam, blood tests, microscopy, culture, and imaging to diagnose primary extrapulmonary coccidioidomycosis. No single test is perfect; results are interpreted together with travel history and risk factors.

Physical examination tests

1. Full general exam with vital signs – The doctor checks temperature, heart rate, breathing rate, blood pressure, and overall appearance. Long-lasting fever, weight loss, and signs of chronic illness increase suspicion of disseminated fungal disease.

2. Skin and soft-tissue examination – The doctor carefully inspects the skin for nodules, plaques, ulcers, abscesses, or warty lesions that could be due to Coccidioides. Lesion pattern and location may suggest systemic spread rather than a local infection only.

3. Joint and bone examination – Joints are checked for swelling, warmth, reduced movement, and pain. Bones and spine are palpated for tenderness that may indicate osteomyelitis or vertebral involvement.

4. Neurologic and meningeal examination – The doctor looks for neck stiffness, abnormal reflexes, weakness, or cranial nerve problems. These signs may indicate coccidioidal meningitis or brain and spinal cord involvement.

Manual (bedside) tests

5. Joint range-of-motion and stress tests – The examiner gently moves joints through their range and applies mild stress; sharp pain or limitation can help localize infected joints or bones and guide which areas need imaging.

6. Spine palpation and straight-leg-raise test – Pressing along the spine and lifting the straight leg while the patient lies flat can reveal pain from vertebral or nerve-root involvement due to fungal bone disease or epidural masses.

7. Bedside cognitive and cranial-nerve screening – Simple tests of memory, orientation, eye movements, facial strength, and speech help detect subtle brain or cranial nerve problems from meningitis or CNS lesions.

Laboratory and pathological tests

8. Complete blood count (CBC) – CBC may show anemia, high white blood cell count, or eosinophilia, which support the presence of a chronic infection but are not specific. Changes can guide overall assessment of disease burden.

9. Inflammatory markers (ESR and CRP) – Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are often raised in active disseminated infection and can be followed over time to monitor response to treatment.

10. Serum coccidioidal antibody EIA (IgM and IgG) – Enzyme immunoassays (EIA) detect early IgM and later IgG antibodies. These tests are widely available and are often the first step to confirm exposure or active disease.

11. Complement fixation and immunodiffusion tests – These older serologic tests measure specific antibodies and can roughly reflect disease severity; higher complement fixation titers are more often seen in disseminated disease, though exceptions occur.

12. Coccidioides antigen tests in serum, urine, or CSF – Antigen tests detect fungal components in body fluids, especially useful in severe or disseminated cases and in patients with weak antibody responses, such as those who are immunosuppressed.

13. Fungal culture from tissue or body fluids – Culturing the fungus from skin biopsies, bone samples, joint fluid, or CSF is considered a gold standard, because it proves the organism is present, but it may take time and requires special lab safety.

14. Histopathology with special stains – Biopsy of skin, bone, lymph node, or meninges examined under a microscope can show characteristic spherules of Coccidioides, especially with silver or PAS stains, giving a firm tissue diagnosis.

15. Cerebrospinal fluid (CSF) analysis for meningitis – In suspected coccidioidal meningitis, lumbar puncture allows testing of CSF for cell counts, protein, glucose, antibodies, and antigens, which helps confirm infection of the central nervous system.

Electrodiagnostic tests

16. Electroencephalography (EEG) – In patients with seizures or altered mental state due to coccidioidal brain involvement, EEG can show abnormal electrical activity and help rule out other causes of seizures or encephalopathy.

17. Nerve conduction studies and electromyography (EMG) – These tests are rarely needed but may be useful if there is suspected peripheral nerve damage from spinal or meningeal disease compressing nerve roots.

Imaging tests

18. Plain X-rays of bones and joints – X-rays can show bone destruction, lytic lesions, or joint space damage typical of chronic fungal osteomyelitis or arthritis, guiding further imaging or biopsy.

19. CT scan (especially chest and spine) – CT can detect subtle bone destruction, paraspinal masses, or residual lung lesions. It is helpful in planning surgery or biopsy in complex spinal or chest disease.

20. MRI of brain, spine, and soft tissues – MRI is the best test for coccidioidal meningitis, spinal involvement, and soft-tissue abscesses, showing inflammation, fluid collections, and nerve compression in great detail.

Non-pharmacological (non-drug) treatments

Note: These methods support medical antifungal treatment; they do not replace prescription antifungal drugs.

1. Rest and energy pacing
   In primary extrapulmonary coccidioidomycosis, long-lasting fatigue and pain are common. Planned rest during the day lets the immune system focus on fighting the fungus and reduces flare-ups of bone and joint pain. Energy pacing means spreading tasks through the day, avoiding sudden heavy work, and listening to early signs of tiredness. This approach can shorten recovery time and help people stay independent while they take long-term antifungal medicines.[4][5]

2. Good sleep hygiene
   Deep, regular sleep supports immunity and healing. Simple steps include going to bed at the same time, using a dark and quiet bedroom, avoiding screens before sleep, and limiting caffeine late in the day. Better sleep may reduce pain sensitivity, improve mood, and help the body respond better to antifungal drugs and other treatments.

3. Hydration and balanced fluids
   Drinking enough water keeps blood volume and kidney function stable, which is especially important when taking potentially kidney-toxic medicines such as amphotericin B. Adequate fluids also help maintain blood pressure in very ill patients and can reduce side effects like dizziness and constipation. In people with heart or kidney problems, fluid intake must be guided by a doctor.

4. Nutrition optimization and adequate protein
   Chronic fungal infections increase the body’s protein needs for healing tissues and maintaining muscles. Eating enough protein (from eggs, fish, beans, or lean meat) plus fruits, vegetables, and whole grains supports immune cells and wound healing. Malnutrition is linked with poorer outcomes in serious infections, so seeing a dietitian can be very helpful in complex cases.

5. Smoking cessation and avoiding second-hand smoke
   Even in extrapulmonary disease, the lungs are usually the first target of Coccidioides. Smoking injures airway defenses and makes it harder to clear residual lung infection or handle later lung damage. Stopping smoking improves oxygen delivery to tissues and lowers the risk of further infections and poor wound healing, especially around bone and skin lesions.

6. Alcohol reduction or avoidance
   Many antifungal drugs can stress the liver. Alcohol also injures liver cells and can strongly increase the risk of drug-induced liver damage. Avoiding alcohol reduces this risk and lets doctors give effective antifungal doses more safely. It also improves sleep and mood in many patients.

7. Physical therapy for bones and joints
   When the fungus infects bones or joints, people may develop chronic pain, stiffness, and muscle weakness. A physical therapist can design safe exercises to keep joints moving, protect weakened bone areas, improve balance, and maintain muscle strength. This can reduce disability, lower fracture risk, and support independence while antifungals control the infection.[1][3]

8. Occupational therapy and activity modification
   Occupational therapists help patients adapt daily tasks—like bathing, dressing, or work activities—so they can be done with less pain and fatigue. They may suggest assistive devices, safer body mechanics, and pacing strategies. This is especially important when the spine, pelvis, or weight-bearing joints are involved.

9. Bracing, splints, or orthotic devices
   For bone lesions in the spine, long bones, or joints, external supports such as back braces or orthotics can reduce stress on damaged structures and help prevent fractures or deformity. These devices are usually used together with surgery or antifungal therapy, not instead of treatment.

10. Local wound and skin care
    Cutaneous or soft-tissue lesions can drain or ulcerate. Gentle daily cleaning, non-stick dressings, and protection from trauma lower the risk of secondary bacterial infection and scarring. In some cases, compression bandages help limit swelling around involved limbs.

11. Psychological support and counseling
    Extrapulmonary coccidioidomycosis is often chronic, painful, and frightening. Anxiety and depression are common when people face long-term treatment and uncertain outcomes. Counseling, support groups, relaxation training, and sometimes online therapy can help patients cope, adhere to medication plans, and maintain social and family roles.

12. Pain self-management strategies
    Alongside pain medicines, non-drug methods such as heat or cold packs, gentle stretching, breathing exercises, mindfulness, and distraction techniques can reduce the perception of pain. These approaches empower patients and may reduce the dose of strong painkillers needed.

13. Infection-control habits at home
    Coccidioidomycosis is not spread from person to person, but patients with weakened immunity are prone to other infections. Frequent hand-washing, up-to-date routine vaccinations (as advised by doctors), and avoiding contact with people who are acutely ill help prevent additional illnesses that could worsen the course of the fungal disease.[3][6]

14. Avoiding new dust exposure in endemic areas
    In regions where the fungus is common, patients should avoid digging in dry soil, dust storms, and construction zones. Wearing well-fitting masks (for example, N95-type respirators) and wetting soil before gardening may lower the chance of inhaling new spores, which could cause more lesions.

15. Blood sugar and chronic disease control
    Diabetes, kidney disease, and chronic lung disease increase the risk of severe or disseminated coccidioidomycosis. Tight control of blood sugar, blood pressure, and other chronic conditions improves immune function and lowers complications from antifungal drugs.

16. Weight management and gentle aerobic activity
    When allowed by the doctor, light walking or low-impact exercises help maintain heart and lung fitness, prevent deconditioning, and improve mood. A healthy weight is linked with better surgical outcomes and lower drug-related complications. Activity must be tailored to protect infected bones and joints.

17. Sun protection for skin lesions and scars
    Areas of skin affected by the infection or surgery scars can darken or scar more if exposed to strong sunlight. Using sunscreen, hats, and clothing protects cosmetic appearance and may lower irritation or itching.

18. Fall-prevention strategies
    Bone involvement, muscle weakness, and certain medicines (like sedatives or strong painkillers) increase fall risk. Removing loose rugs, using grab bars, ensuring good lighting, and using canes or walkers when needed help prevent fractures in weakened bones.

19. Education about warning signs and adherence
    Understanding the disease, treatment length, lab monitoring, and warning symptoms (for example, new headaches or back pain) is key. Educated patients are more likely to take medicines correctly, attend follow-up appointments, and seek help early if things worsen.

20. Social and financial support planning
    Long-term treatment may affect work, school, and family life. Involving social workers or patient-support organizations early can help with insurance issues, travel for specialist care, and mental health support, improving long-term outcomes.

---

Drug treatments

Very important: Doses below are typical ranges from guidelines and prescribing information, not personal medical advice. Only a qualified doctor can decide the right drug and dose for an individual person.[1][2][3][7][8][9]

1. Fluconazole (DIFLUCAN – triazole antifungal)
   Fluconazole is often the first-line oral drug for many extrapulmonary forms, especially skin, soft-tissue, and some bone disease. It blocks fungal ergosterol synthesis, weakening the cell membrane so the fungus cannot grow. Typical adult doses for serious disease are 400–800 mg once daily, and even higher (up to 1200 mg) in meningitis, often for months or years.[1][3][7] Common side effects include nausea, headache, liver enzyme elevation, and drug interactions via CYP450 inhibition.[4]

2. Itraconazole (SPORANOX – triazole antifungal)
   Itraconazole is frequently preferred for bone and joint coccidioidomycosis because it may penetrate bone well.[1][9] Usual doses are 200 mg two or three times daily with food. It also blocks ergosterol synthesis and is used long-term after initial control of severe disease. Side effects include gastrointestinal upset, liver toxicity, ankle swelling, and many drug interactions; blood level monitoring is often recommended.

3. Ketoconazole (NIZORAL – triazole antifungal)
   Ketoconazole was historically the only azole specifically FDA-approved for coccidioidomycosis, usually at 200–400 mg daily.[9] It also inhibits ergosterol synthesis but has significant risk of liver injury and hormone-related side effects (such as reduced testosterone and cortisol). Because safer azoles exist, it is now rarely used, but it remains an important historical drug in guidelines and older studies.

4. Amphotericin B deoxycholate (FUNGIZONE – polyene antifungal)
   For very severe or rapidly progressive extrapulmonary disease (for example, spinal involvement with cord compression or widespread bone lesions), intravenous amphotericin B is recommended as initial therapy.[1][3][8] Typical doses are around 0.7–1.0 mg/kg/day, given through a vein. It binds ergosterol and creates pores in fungal membranes, killing the fungus. Main side effects include kidney damage, low potassium and magnesium, fever, chills, and infusion reactions, so close monitoring is essential.[10]

5. Liposomal amphotericin B (AmBisome – polyene antifungal)
   Liposomal formulations deliver amphotericin B inside tiny fat bubbles, allowing higher doses with less kidney toxicity. Doses often range 3–5 mg/kg/day. They are commonly used when standard amphotericin is poorly tolerated or when long IV courses are required for serious bone, joint, or CNS disease. Side effects include infusion reactions and liver or kidney test abnormalities but tend to be milder than the conventional formulation.[10]

6. Amphotericin B lipid complex (ABLC – polyene antifungal)
   This alternative lipid formulation is used in some centers for severe disseminated disease. It works similarly to other amphotericin B forms but may have different toxicity and dosing characteristics (often 5 mg/kg/day). Like other formulations, careful monitoring of kidney function and electrolytes is mandatory.

7. Posaconazole (NOXAFIL – triazole antifungal)
   Posaconazole is a broad-spectrum oral and IV azole used for difficult or refractory fungal infections. For chronic disseminated coccidioidomycosis that fails fluconazole or itraconazole, specialists may use posaconazole off-label, guided by levels and response.[3] Typical dosing is 300 mg twice on day 1, then 300 mg once daily for tablets. Side effects include nausea, liver enzyme increases, and many drug interactions.[5]

8. Voriconazole (VFEND – triazole antifungal)
   Voriconazole, given IV or orally, has excellent tissue penetration and is sometimes used for severe, resistant coccidioidomycosis. A common regimen is 6 mg/kg IV every 12 hours for two doses, then 4 mg/kg IV every 12 hours, or 200 mg orally every 12 hours in adults.[6] Side effects include visual disturbances, photosensitivity, liver test abnormalities, and drug interactions.

9. Isavuconazonium sulfate (CRESEMBA – triazole antifungal)
   Isavuconazonium is a newer broad-spectrum azole. HIV-OI guidelines list it as an option for certain severe mold infections and in some cases of coccidioidomycosis when other azoles cannot be used.[2] Loading doses are 372 mg (equivalent to 200 mg isavuconazole) every 8 hours for six doses, then 372 mg once daily. Major side effects include liver enzyme increases, nausea, and QT interval shortening, so ECG monitoring may be needed.[2][6]

10. Caspofungin and other echinocandins (MICAFUNGIN, ANIDULAFUNGIN – echinocandin antifungals)
    Echinocandins inhibit fungal cell wall synthesis. They are not first-line drugs for coccidioidomycosis, but in rare, difficult cases specialists may combine them with azoles or amphotericin based on limited data.[3][16] Doses vary by drug (for example, micafungin 100 mg IV daily). Side effects include liver test elevation and infusion-related reactions.

11. Acetaminophen (paracetamol – analgesic/antipyretic)
    Acetaminophen helps control fever and mild to moderate pain from bone, joint, or soft-tissue lesions. It works in the brain to reduce pain perception and fever but does not kill the fungus. Usual adult doses are up to 650–1000 mg every 6 hours (maximum daily dose depends on country and liver status). Liver toxicity can occur at high doses or with alcohol or other hepatotoxic drugs, so doctors must set safe limits.

12. Non-steroidal anti-inflammatory drugs (NSAIDs – e.g., ibuprofen, naproxen)
    NSAIDs reduce pain and inflammation in joints and bones by blocking cyclo-oxygenase enzymes and lowering prostaglandins. Typical adult doses might be ibuprofen 400–600 mg every 6–8 hours with food. They can cause stomach irritation, ulcers, kidney problems, and increased bleeding risk, especially when combined with other drugs, so they must be used carefully.

13. Opioid analgesics (e.g., morphine, oxycodone – strong painkillers)
    Severe bone pain or post-surgical pain sometimes needs opioid medicines for short periods. They act on opioid receptors in the brain and spinal cord to reduce pain perception. Dosing is highly individualized. Side effects include constipation, drowsiness, nausea, and risk of dependence; therefore they are reserved for carefully monitored situations.

14. Corticosteroids (e.g., dexamethasone, prednisone – anti-inflammatory/immunomodulator)
    In general, steroids can worsen many fungal infections, but in selected situations—such as severe coccidioidal meningitis with increased intracranial pressure—experts sometimes use short steroid courses alongside antifungals to reduce dangerous inflammation.[1][2] They suppress immune activity and swelling, which can protect vital structures like the spinal cord, but they also increase infection risk, so doses and duration must be as low and short as possible.

15. Antiemetics (e.g., ondansetron – serotonin 5-HT3 antagonist)
    Many antifungals, especially azoles and amphotericin B, cause nausea and vomiting. Ondansetron blocks serotonin receptors in the gut and brain that trigger vomiting, helping patients tolerate long-term therapy. Typical adult dosing is 4–8 mg every 8 hours as needed. Side effects include constipation and rare heart rhythm changes at high doses.

16. Proton pump inhibitors or H2 blockers (e.g., omeprazole, famotidine)
    Patients taking NSAIDs or steroids have higher risk of stomach ulcers and bleeding. Acid-suppressing drugs reduce stomach acid and protect the lining, lowering ulcer risk. However, some azoles (like itraconazole capsules) need acidic stomach conditions for best absorption, so doctors must balance acid suppression with antifungal effectiveness.

17. Electrolyte supplements (e.g., potassium, magnesium)
    Amphotericin B often causes low potassium and magnesium levels. Oral or IV supplements restore these electrolytes, supporting heart rhythm and muscle function. Doses are based on blood tests and must be adjusted to avoid high levels, especially in patients with kidney disease.

18. Antihistamines (e.g., diphenhydramine) for infusion reactions
    Infusions of amphotericin B or other IV drugs can cause fever, chills, or allergic-type reactions. Antihistamines and sometimes acetaminophen are given before infusions to reduce these symptoms. They block histamine receptors and lessen itching, rash, and flushing, but can cause drowsiness.

19. Intravenous fluids (e.g., normal saline)
    Before and after amphotericin B infusions, IV saline is often used to protect the kidneys and maintain blood pressure. Fluids support kidney perfusion and help reduce nephrotoxicity. Doctors adjust speed and volume based on heart, kidney, and lung function.

20. Broad-spectrum antibiotics when secondary bacterial infection occurs
    If lesions or surgical sites become secondarily infected with bacteria, appropriate antibiotics may be needed. These drugs do not treat the fungus but control added bacterial infections that can worsen outcomes. Choice and dose depend on culture results and clinical setting.

---

Dietary molecular supplements

Evidence for supplements specifically in coccidioidomycosis is limited. They must not replace antifungal drugs. Always discuss supplements with your doctor, especially when taking azole antifungals that have many drug interactions.[3][5]

1. Vitamin D
   Vitamin D supports normal immune responses and may help the body recognize and clear infections more effectively. Typical adult supplemental doses range from 600–2000 IU daily, adjusted to blood levels. It works by binding to vitamin D receptors on immune cells and influencing cytokine production. Excessive doses can cause high calcium levels, kidney stones, and confusion, so monitoring is important.

2. Vitamin C (ascorbic acid)
   Vitamin C is an antioxidant that supports white blood cell function and collagen formation, which is important for healing surgical wounds or skin lesions. Common doses are 250–1000 mg/day. It helps neutralize free radicals produced during inflammation. Very high doses may cause stomach upset or kidney stones in susceptible people.

3. Zinc
   Zinc is crucial for normal T-cell and neutrophil function. Typical supplement doses are 10–25 mg elemental zinc per day. It serves as a cofactor for many enzymes and helps immune cells respond to pathogens. Long-term high doses can cause nausea, copper deficiency, and lowered HDL (“good”) cholesterol.

4. Selenium
   Selenium is an antioxidant trace mineral involved in glutathione peroxidase activity and immune regulation. Low selenium may worsen outcomes in some infections. Supplemental doses are usually 50–200 mcg per day. Excess selenium can cause hair loss, brittle nails, and nerve problems, so dosing should stay near recommended limits.

5. Omega-3 fatty acids (fish oil, EPA/DHA)
   Omega-3 fats have anti-inflammatory effects by altering eicosanoid and cytokine production. Typical doses are 500–1000 mg combined EPA/DHA daily, sometimes higher under medical supervision. They may help joint pain and overall inflammation but can slightly increase bleeding risk at high doses, especially with anticoagulants.

6. Probiotics
   Probiotics (such as Lactobacillus and Bifidobacterium species) aim to support a healthy gut microbiome, which interacts with systemic immunity. Typical doses are 1–10 billion CFU daily. They may reduce antibiotic-associated diarrhea and support mucosal immunity. In severely immunocompromised patients, probiotic use must be carefully discussed, as rare bloodstream infections have been reported.

7. Glutamine
   Glutamine is an amino acid fuel for rapidly dividing cells, including immune and gut lining cells. Supplemental doses of 5–10 g per day are sometimes used in critical illness. It may help maintain gut barrier function and reduce muscle breakdown, but evidence is mixed, and high doses can cause gastrointestinal discomfort.

8. Curcumin (from turmeric)
   Curcumin has anti-inflammatory and antioxidant properties through modulation of NF-κB and other pathways. Typical supplemental doses range around 500–1000 mg curcumin extract daily with piperine to improve absorption. It may ease joint pain and inflammation but can interact with blood thinners and affect drug metabolism enzymes.

9. Beta-glucans (from yeast or mushrooms)
   Beta-glucans can stimulate innate immunity by binding to receptors on macrophages and neutrophils, enhancing pathogen recognition. Doses vary widely (often 250–500 mg/day of standardized extracts). They might improve general immune readiness, but high-quality data for coccidioidomycosis are lacking.

10. Whey protein or other high-quality protein powders
    For patients with low appetite or weight loss, protein powders supply easily digestible amino acids to support muscle mass and immune proteins (antibodies, complement). Typical servings provide 20–25 g protein once or twice daily. People with kidney disease must discuss protein intake with their nephrologist.

---

Advanced immune-support / regenerative therapies

There are no standard “stem cell drugs” specifically approved for extrapulmonary coccidioidomycosis. The options below are examples of therapies that may be used in special situations to support immunity or treat underlying problems, always under specialist care.

1. Granulocyte colony-stimulating factor (G-CSF – filgrastim)
   Filgrastim is an injectable protein that stimulates the bone marrow to produce more neutrophils. In patients with severe neutropenia from chemotherapy or other causes, G-CSF can improve the body’s ability to fight fungal infections, including coccidioidomycosis. Dosing is usually weight-based and given daily or several times a week. Side effects include bone pain and, rarely, spleen problems.

2. Granulocyte–macrophage colony-stimulating factor (GM-CSF – sargramostim)
   GM-CSF boosts both neutrophil and macrophage function. It has been used experimentally as an adjunctive therapy in some refractory fungal infections. Doses are given by injection and adjusted to blood counts. It may cause fever, bone pain, and fluid retention, so close monitoring is required.

3. Interferon-gamma (IFN-γ)
   Interferon-gamma is a cytokine that enhances macrophage and T-cell activity against intracellular pathogens. In certain rare, severe fungal infections, IFN-γ has been used off-label to improve immune response. It is injected subcutaneously several times per week. Side effects include flu-like symptoms and possible liver test changes.

4. Intravenous immunoglobulin (IVIG)
   IVIG consists of pooled antibodies from healthy donors. In patients with antibody deficiencies or complex immune problems, IVIG can help restore part of normal immune function. It is given by IV infusion every few weeks. Potential side effects include headache, kidney stress, and rare allergic or clotting events.

5. Hematopoietic stem cell transplantation (HSCT) for underlying disorders
   HSCT is not a treatment for coccidioidomycosis itself, but in people with severe blood or immune diseases, a stem cell transplant may eventually normalize immunity, reducing long-term infection risk. It involves intensive chemotherapy or radiation followed by infusion of donor stem cells. Risks include severe infections, graft-versus-host disease, and organ toxicity.

6. Experimental mesenchymal stem-cell or regenerative trials
   Some research is exploring mesenchymal stem-cell therapies or other regenerative approaches for immune modulation and tissue repair in severe infections. These treatments are experimental and only available in clinical trials. They may help reduce inflammation and aid bone or tissue healing, but safety and effectiveness in coccidioidomycosis are not yet proven.

---

Surgeries (procedures and why they are done)

1. Surgical debridement of infected bone (osteomyelitis)
   When the fungus destroys bone or causes chronic draining sinuses, surgeons may remove infected and dead bone tissue. Debridement reduces fungal load, improves penetration of antifungal drugs, and stabilizes the area. It is often followed by long-term azole therapy or amphotericin B.[1][3][4]

2. Spinal stabilization and decompression
   Vertebral coccidioidomycosis can collapse vertebrae and compress the spinal cord. Surgery may remove diseased bone, decompress the spinal cord, and place hardware (rods, screws) to stabilize the spine. This prevents paralysis and reduces severe pain, while antifungal therapy controls the infection.

3. Drainage or excision of soft-tissue abscesses
   Soft-tissue or muscle abscesses caused by Coccidioides can persist despite drugs. Incision and drainage or complete excision remove pus and fungal masses, relieve pain, and allow pathologic confirmation. It also lowers fungal burden and improves drug penetration into the area.

4. Neurosurgical procedures for meningitis complications
   In coccidioidal meningitis, increased intracranial pressure or hydrocephalus may require shunt placement or other neurosurgical interventions. These procedures divert cerebrospinal fluid to another body cavity, lowering pressure on the brain and preventing life-threatening complications, while azoles are continued long-term.[1][3]

5. Resection of large localized masses (granulomas)
   Sometimes the infection forms a well-defined mass in bone or soft tissue that causes pain, deformity, or risk of fracture. Surgical removal of the mass, with reconstruction when needed, can restore function and reduce symptoms. Histology confirms the diagnosis and rules out cancer.

---

Key prevention strategies

1. Avoid or limit dust exposure in endemic regions (for example, certain areas of the U.S. Southwest and parts of Latin America) by staying indoors during dust storms and avoiding off-road or desert activities when possible.[10][11]

2. When dusty work is unavoidable (construction, farming, military training), use well-fitting masks (such as N95-type respirators) and wet down soil before digging.

3. People with weak immunity (HIV, organ transplant, long-term steroids, biologic therapies) should discuss travel and work-related dust exposure with their doctor and consider additional precautions or alternative duties.[2][14]

4. Keep chronic illnesses such as diabetes, kidney disease, and chronic lung disease well controlled to lower risk of severe disseminated infection.

5. Follow antifungal treatment plans exactly as prescribed; do not stop early even if symptoms improve, because relapse is common in extrapulmonary disease.[1][3]

6. Attend all follow-up visits and recommended lab tests to detect drug side effects or early recurrence.

7. Avoid unnecessary immunosuppressive medicines when possible; if they are essential (for example, after transplant), infectious-disease specialists should help plan prevention and monitoring.

8. Practice general infection prevention: frequent hand-washing, vaccinations as recommended, and avoiding close contact with people who have severe acute infections.

9. Educate family and caregivers that coccidioidomycosis is not spread person-to-person, reducing stigma and encouraging early medical care.[11]

10. Seek early medical evaluation if you live in or visit endemic areas and develop persistent fever, cough, or unexplained bone, joint, or skin problems.

---

When to see a doctor (or emergency care)

You should see a doctor urgently if you have ever been told you have coccidioidomycosis and you notice:

• New or worsening severe bone or joint pain, especially in the spine, hips, or legs.

• New skin lumps, ulcers, or draining lesions that grow or spread.

• Persistent fever, night sweats, weight loss, or extreme fatigue lasting more than two weeks.

• Severe headache, neck stiffness, confusion, seizures, or visual changes, which may signal meningitis.

• Weakness, numbness, or loss of control in the legs, which may indicate spinal cord compression.

• Yellow eyes or dark urine while on antifungal drugs (possible liver injury).

Emergency services are needed if there is difficulty breathing, chest pain, sudden weakness or paralysis, seizures, or severe confusion. Early treatment greatly improves outcomes in extrapulmonary disease.[1][3][16]

---

What to eat and what to avoid

These are general healthy-infection-recovery tips, not a special “cure” diet. Always adjust for allergies, kidney, liver, or diabetes conditions.

1. Eat: Lean protein such as fish, eggs, beans, lentils, and poultry to support muscle and immune proteins.

2. Eat: Colorful fruits and vegetables rich in vitamins A, C, and antioxidants (berries, citrus, leafy greens) to support healing.

3. Eat: Whole grains (oats, brown rice, whole-wheat bread) for steady energy and fiber, which helps bowel function when using pain medicines.

4. Eat: Healthy fats from olive oil, nuts, seeds, and fatty fish to provide energy and anti-inflammatory omega-3 fatty acids.

5. Eat: Fermented foods (yogurt with live cultures, kefir, kimchi) if tolerated, to support gut microbiome health when taking long-term medicines.

6. Avoid: Excess sugar-sweetened drinks and desserts, which can worsen inflammation, weight gain, and blood sugar control.

7. Avoid: Heavy alcohol use, because it increases liver damage risk when combined with azole antifungals or other drugs.

8. Avoid: Very salty processed foods (instant noodles, chips, processed meats) if you have heart or kidney problems, especially while on IV fluids or certain drugs.

9. Avoid: Undercooked meat, unpasteurized dairy, or unsafe street food if you are immunocompromised, to reduce the risk of other infections.

10. Avoid: High-dose herbal products without medical advice, especially those that can affect liver enzymes (for example, some traditional remedies), because they may interact with antifungal drugs.

---

Frequently asked questions (FAQs)

1. Is primary extrapulmonary coccidioidomycosis curable?
   Many patients can achieve very good control or remission with long-term antifungal therapy and, when needed, surgery. However, some people—especially those with bone or CNS disease—may need years of treatment or even lifelong suppressive azole therapy to prevent relapse.[1][3]

2. How long will I need antifungal treatment?
   For extrapulmonary disease, treatment is often measured in months to years, not weeks. Guidelines suggest 1–2 years or longer for bone and soft-tissue disease, and often lifelong therapy for meningitis, depending on clinical response and immune status.[1][3][16]

3. Can this infection spread from person to person?
   No. Human-to-human transmission does not occur. People become infected by inhaling spores from contaminated soil and dust, not from casual contact with patients.[10][11]

4. Why did my infection go outside the lungs?
   After inhalation, spores can travel through the bloodstream or lymphatic system. Risk is higher in people with weak cellular immunity (HIV, organ transplant, long-term steroids), certain genetic or ethnic backgrounds, pregnancy, or uncontrolled diabetes.[2][3]

5. What tests are used to monitor my disease?
   Doctors may order blood antibody titers, imaging (X-ray, CT, MRI), bone scans, CSF analysis for meningitis, and sometimes biopsies of lesions. These tests help follow fungal burden, treatment response, and complications.[1][3][16]

6. Can I stop my medicine when I feel better?
   Stopping antifungal medicine early is a major cause of relapse, especially in extrapulmonary disease. You should only change or stop treatment under guidance of your infectious-disease specialist, after careful review of symptoms, imaging, and lab tests.[1][3]

7. What side effects should I watch for with azole antifungals?
   Common issues include nausea, abdominal discomfort, headache, and skin rash. More serious problems are liver injury (yellow eyes, dark urine, severe fatigue), heart rhythm changes, and drug interactions. Regular blood tests and reporting new symptoms promptly are essential.[4][5][7]

8. Is amphotericin B always necessary for severe disease?
   Amphotericin B is strongly recommended for life-threatening or rapidly progressive disseminated disease, especially with CNS or severe bone involvement. Once the infection is controlled, therapy often switches to a long-term oral azole.[1][2][3]

9. Can I become reinfected after treatment?
   Past infection usually provides some immunity, but reinfection can still occur, especially with heavy exposure to dust in endemic areas or if your immune system becomes weak again. Prevention measures and follow-up remain important.

10. Does pregnancy change treatment?
    Pregnancy increases the risk of severe or disseminated coccidioidomycosis. Choice of antifungal therapy must carefully balance maternal and fetal risks, and treatment is best managed by a team including infectious-disease, obstetric, and possibly neonatal specialists.[1][2]

11. Are there vaccines for coccidioidomycosis?
    At present, there is no licensed vaccine for humans, although research is ongoing to develop vaccines for people living in highly endemic regions.[3]

12. Can I work or go to school during treatment?
    Many patients can continue work or study with adjustments, depending on the severity of disease and type of job. Heavy physical labor, dusty environments, or jobs requiring intense concentration may need temporary changes. Occupational therapy and employer or school accommodation can help.

13. Will I always have pain?
    Pain can often be significantly reduced with effective antifungal therapy, surgery when needed, and a combination of medications and non-drug pain strategies. Some people may have chronic pain from previous bone damage, but multidisciplinary pain management can greatly improve quality of life.

14. Should my family members be tested?
    Routine testing of family members is not required, because the disease is not spread person-to-person. However, if family members share the same environmental exposure (for example, dust storms or occupational dust), they should be educated about symptoms and seek medical evaluation if they become unwell.

15. What is the most important thing I can do to help my recovery?
    The most important steps are: take antifungal medicine exactly as prescribed, keep all appointments and lab tests, communicate side effects early, protect yourself from new dust exposure, maintain a healthy lifestyle (sleep, nutrition, mental health), and work closely with your healthcare team. These actions together give the best chance of long-term control of primary extrapulmonary coccidioidomycosis.[1][3][5]

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: February 01, 2025.